Avalo Therapeutics, Inc. (AVTX)
Company Info
| ISIN | US05338F1084 |
|---|---|
| CUSIP | 05338F108 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $4.80 |
|---|---|
| Year Range | $3.00 - $32.88 |
| EMA (50) | $4.89 |
| EMA (200) | $11.55 |
| Average Volume | $58.57K |
| Market Capitalization | $45.19M |
AVTXShare Price Chart
Click Calculate to get results
AVTXPerformance
The chart shows the growth of $10,000 invested in Avalo Therapeutics, Inc. in Nov 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,000 for a total return of roughly -90.00%. All prices are adjusted for splits and dividends.
AVTXReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 37.14% | -4.08% |
| 6M | -44.11% | -10.07% |
| YTD | -76.47% | -17.66% |
| 1Y | -87.65% | -13.26% |
| 5Y | -11.34% | 9.65% |
| 10Y | -28.79% | 10.35% |
AVTXMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -42.18% | -25.71% | -0.75% | -43.31% | -12.34% | 38.85% | -40.00% | 31.94% | 1.05% | |||
| 2021 | 19.32% | 6.98% | -10.39% | 3.97% | -15.92% | 23.86% | -18.65% | 16.54% | -29.68% | 7.34% | -14.53% | -15.00% |
| 2020 | -26.72% | -22.78% | -18.69% | -4.44% | 36.29% | -19.50% | 5.00% | -9.89% | -7.52% | -9.45% | 21.36% | 5.60% |
| 2019 | 60.99% | 37.69% | -18.44% | -6.85% | -10.29% | 11.48% | -25.92% | -19.60% | 1.54% | 4.56% | 9.59% | 42.97% |
| 2018 | 3.44% | 40.79% | -7.94% | -13.29% | 11.56% | 4.58% | 2.30% | 8.78% | -3.31% | -12.21% | -14.39% | -7.98% |
| 2017 | -4.02% | -13.61% | -7.52% | -34.53% | 13.26% | 14.46% | 23.91% | 3.10% | 16.13% | 32.93% | 57.52% | 79.78% |
| 2016 | -6.18% | 3.72% | 14.42% | 3.75% | -39.53% | -5.98% | 72.73% | 5.26% | 5.75% | -12.06% | -44.09% | -57.67% |
| 2015 | 5.00% | -20.24% |
AVTXDividend History
Avalo Therapeutics, Inc. doesn't pay dividends
AVTXDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
AVTXWorst Drawdowns
The table below shows the maximum drawdowns of the Avalo Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Avalo Therapeutics, Inc. is 96.54%, recorded on May 11, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.54% | Feb 28, 2019 | 808 | May 11, 2022 | — | — | — |
| -91.55% | Nov 25, 2016 | 106 | Apr 28, 2017 | 215 | Mar 7, 2018 | 321 |
| -60.57% | Mar 18, 2016 | 55 | Jun 6, 2016 | 117 | Nov 18, 2016 | 172 |
| -46.64% | Mar 8, 2018 | 204 | Dec 27, 2018 | 39 | Feb 25, 2019 | 243 |
| -35.56% | Nov 19, 2015 | 47 | Feb 1, 2016 | 30 | Mar 16, 2016 | 77 |
| -5.56% | Nov 17, 2015 | 1 | Nov 17, 2015 | 1 | Nov 18, 2015 | 2 |
AVTXVolatility Chart
Current Avalo Therapeutics, Inc. volatility is 27.91%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.